基于患者标本的唐氏综合征产前筛查自动化校正方案探讨

doi:10.16150/j.1671-2870.2018.05.012

诊断学理论与实践 ›› 2018, Vol. 17 ›› Issue (05): 547-551.doi: 10.16150/j.1671-2870.2018.05.012

基于患者标本的唐氏综合征产前筛查自动化校正方案探讨

张海鸥^a, 程蔚蔚^b, 胡雯婧^a, 刘朦迪^a, 范建霞^b, 钱义元^a

上海交通大学医学院附属国际和平妇幼保健院a. 生殖遗传科; b. 围产科,上海 200030

收稿日期:2017-10-01 出版日期:2018-10-25 发布日期:2018-10-25
通讯作者: 张海鸥 E-mail: www.sea66@163.com
基金资助:
上海申康医院发展中心新兴前沿技术项目（SHDC12013114）; 上海卫计委三年行动计划（No.15GWZ K0701）

Exploration of an automated prenatal Down syndrome screening adjustment protocol based on patient samples

ZHANG Haiou^a, CHENG Weiwei^b, HU Wenjing^a, LIU Mengdi^a, FAN Jianxia^b, QIAN Yiyuan^a

a. Reproductive Genetics Laboratory, b. Department of Obstetrics The International Peace Maternity & Child Health Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China

Received:2017-10-01 Online:2018-10-25 Published:2018-10-25

摘要/Abstract

摘要： 目的：探讨基于患者标本的孕中期血清三联唐氏综合征产前筛查自动化校正方案,旨在建立更有效的唐氏综合征产前筛查质量保证体系。方法：对本院2014年的13 024例孕中期孕妇的唐氏征筛查中位数倍数（multiple of medians, MoM）,运用累积和批次校正法进行校正,采用校正中位数倍数中值（median of multiple of medians, mMoM）在0.90~1.10之外的批次（方案一）和校正中位数倍数中值（mMoM）在0.95~1.05之外的批次（方案二）这2种方案得到的MoM值,重新评估孕妇胎儿发生唐氏综合征的风险。结果：采用方案一和方案二2种校正方案分别能把mMoM在0.90~1.10和0.95~1.05的百分比由校正前的64%和90%,提升到校正后的67%、99%和85%、99%。13 024例孕妇的唐氏综合征检出率和阳性率在原始方案和2种校正方案中差异不大。结论：对于孕中期血清三联唐氏综合征产前筛查,临床实验室可考虑在当前质控方案基础上增加自动化校正方案。

关键词: 唐氏综合征, 产前筛查, 质量控制

Abstract: Objective: To explore an automated prenatal Down syndrome screening adjustment protocol for the second trimester triple marker screening to create a better method for prenatal screening with quality assurance. Methods: The multiple of median (MoM) of 13 024 second trimester maternal serum screening samples were adjusted using cumulative sum (CUSUM) adjustment protocol with adjustment targeting median of MoM (mMoM) outside 0.90-1.10 per batch or outside 0.95-1.05 per batch. The Down syndrome risk is recalculated according to the adjusted MoM. Result: Two adjustment protocols improved the percentage of median MoM within 0.90-1.10 and 0.95-1.05 from(64%, 90% to 67%, 99% and 85%, 99%). The differences of detection rate and false positive rate for Down syndrome between the original results and two adjustment protocols were mild. Conclusions: Clinical laboratory should consider the improving of current prenatal screening protocol with our automated CUSUM adjustment protocol.

Key words: Down syndrome, Prenatal screening, Quality control

中图分类号:

R446.13⁺9

张海鸥, 程蔚蔚, 胡雯婧, 刘朦迪, 范建霞, 钱义元. 基于患者标本的唐氏综合征产前筛查自动化校正方案探讨[J]. 诊断学理论与实践, 2018, 17(05): 547-551.

ZHANG Haiou, CHENG Weiwei, HU Wenjing, LIU Mengdi, FAN Jianxia, QIAN Yiyuan. Exploration of an automated prenatal Down syndrome screening adjustment protocol based on patient samples[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 547-551.

参考文献

[1] 何法霖, 王薇, 钟堃, 等. 我国妊娠中期母血清学产前筛查标记物中位数的调查与分析[J]. 中华围产医学杂志,2015,18(10):761-765.
[2] 边旭明, 蒋宇林. 重视唐氏综合征产前筛查质量控制和评价[J]. 实用妇产科杂志,2014,30(2):81-83.
[3] 胡娅莉. 再论产前筛查质量控制的重要性[J]. 中华围产医学杂志,2011,14(2):68-69.
[4] 蒋宇林, 刘俊涛, 刘善英, 等. 唐氏综合征产前筛查指标中位数倍数值中位数监测和质量评价方法的应用分析[J]. 实用妇产科杂志,2014,30(2):103-107.
[5] Currier R, Wu N, Van Meter K, et al.Integrated and first trimester prenatal screening in California: program implementation and patient choice for follow-up services[J]. Prenat Diagn,2012,32(11):1077-1083.
[6] 何法霖, 王薇, 钟堃, 等. 全国妊娠早期母血清学筛查的室间质量评价和室内质量控制结果分析[J]. 中华围产医学杂志,2015,18(8):621-624.
[7] Palomaki GE, Lee JE, Canick JA, et al.Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements[J]. Genet Med,2009,11(9):669-681.
[8] Wald NJ, Rodeck C, Hackshaw AK, et al.First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)[J]. J Med Screen,2003,10(2):56-104.
[9] 陶炯, 刘晓梅, 周钢, 等. 基于生物统计学原则的唐氏综合征产前筛查质量控制和评价[J]. 中国计划生育和妇产科,2016,8(1):14-19.
[10] 赵欣荣, 陶炯, 张海鸥, 等. 妊娠中期母血清学筛查胎儿唐氏综合征的效率——50086例分析[J]. 中华围产医学杂志,2014,17(9):638-641.
[11] Wald NJ, Rodeck C, Hackshaw AK, et al.First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)[J]. Health Technol Assess,2003,7(11):1-77.
[12] 罗军, 沈歈忱, 唐振华. 孕中期三联筛查唐氏综合征和18三体综合征的临床价值[J]. 诊断学理论与实践,2011,10(3):255-259.
[13] 张彬, 岳朝艳, 应春妹. 上海地区中孕期唐氏综合征血清学筛查的应用价值探讨[J]. 诊断学理论与实践,2017, 16(2):213-216.
[14] Li B, Sahota DS, Lao TT, et al. Applicability of first-trimester combined screening for fetal trisomy 21 in a resource-limited setting in mainland China[J]. BJOG,2016, 123 Suppl 3:23-29.
[15] Nix B, Wright D, Baker A.The impact of bias in MoM values on patient risk and screening performance for Down syndrome[J]. Prenat Diagn,2007,27(9):840-845.

基于患者标本的唐氏综合征产前筛查自动化校正方案探讨

Exploration of an automated prenatal Down syndrome screening adjustment protocol based on patient samples

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价

[1]	上海市放射诊断质量控制中心. 新型冠状病毒肺炎防控期间上海市放射诊断质量控制工作的指导意见[J]. 诊断学理论与实践, 2020, 19(1): 11-15.
[2]	郭娟娟, 吴涛, 贾占武, 马利, 白海, 王存邦. WT1阳性急性髓细胞性白血病合并唐氏综合征一例报告[J]. 诊断学理论与实践, 2020, 19(05): 531-533.
[3]	张彬, 岳朝艳, 应春妹. 上海地区中孕期唐氏综合征血清学筛查的应用价值探讨[J]. 诊断学理论与实践, 2017, 16(02): 213-216.
[4]	罗军, 沈觎忱, 唐振华,. 孕中期三联筛查唐氏综合征和18三体综合征的临床价值[J]. 诊断学理论与实践, 2011, 10(03): 255-259.
[5]	吕时铭,. 选择适合我国现状的唐氏综合征产前筛查和诊断模式[J]. 诊断学理论与实践, 2010, 9(05): 413-417.
[6]	刘敬忠,. 现行唐氏综合征筛查方法之我见[J]. 诊断学理论与实践, 2010, 9(05): 418-419.
[7]	薛永权,. 导致恶性血液病染色体R带核型分析失败的原因和对策[J]. 诊断学理论与实践, 2010, 9(04): 390-391.
[8]	蔡徐山, 戴清清, 黄秋兰, 陈怡, 陈宇, 齐结华, 王东江,. 孕中期产前筛查母血清标志物中位数倍数的应用[J]. 诊断学理论与实践, 2009, 8(05): 502-505.
[9]	何萍, 何艳佩, 陈艳华, 王文洁,. 不同抗凝剂对血浆乳酸测定结果的影响[J]. 诊断学理论与实践, 2009, 8(03): 336-337.
[10]	施仲伟,. 重视超声心动图诊断心血管疾病的质量控制[J]. 诊断学理论与实践, 2008, 7(02): 125-127.
[11]	邓德耀, 李增安, 周林华, 支国华,. 质控方案设计工具在室内质量控制中的应用[J]. 诊断学理论与实践, 2005, 4(05): 406-409.